uric acid has been researched along with bof 4272 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nishino, T; Sato, S; Tatsumi, K | 1 |
| Nakashima, M; Uematsu, T | 1 |
| Naito, S; Nishimura, M; Tamao, Y | 1 |
1 trial(s) available for uric acid and bof 4272
| Article | Year |
|---|---|
Pharmacokinetic and pharmacodynamic properties of a novel xanthine oxidase inhibitor, BOF-4272, in healthy volunteers.
Topics: Adult; Half-Life; Humans; Male; Reference Values; Triazines; Uric Acid; Xanthine Dehydrogenase; Xanthine Oxidase | 1994 |
2 other study(ies) available for uric acid and bof 4272
| Article | Year |
|---|---|
A novel xanthine dehydrogenase inhibitor (BOF-4272).
Topics: Allopurinol; Animals; Humans; Hypoxanthine; Hypoxanthines; Intestine, Small; Kinetics; Liver; Lung; Male; Mice; Mice, Inbred ICR; Reference Values; Species Specificity; Triazines; Urate Oxidase; Uric Acid; Xanthine; Xanthine Dehydrogenase; Xanthine Oxidase; Xanthines | 1991 |
Evaluation of the pharmacological actions and pharmacokinetics of BOF-4272, a xanthine oxidase inhibitor, in mouse liver.
Topics: Animals; Enzyme Inhibitors; Half-Life; Liver; Male; Mice; Tissue Distribution; Triazines; Uric Acid | 2000 |